The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Sarcoidosis, Pulmonary

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Sarcoidosis, Pulmonary

 

High impact information on Sarcoidosis, Pulmonary

 

Chemical compound and disease context of Sarcoidosis, Pulmonary

 

Biological context of Sarcoidosis, Pulmonary

 

Anatomical context of Sarcoidosis, Pulmonary

 

Gene context of Sarcoidosis, Pulmonary

 

Analytical, diagnostic and therapeutic context of Sarcoidosis, Pulmonary

References

  1. Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Rennard, S.I., Hunninghake, G.W., Bitterman, P.B., Crystal, R.G. Proc. Natl. Acad. Sci. U.S.A. (1981) [Pubmed]
  2. Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14. Striz, I., Zheng, L., Wang, Y.M., Pokorná, H., Bauer, P.C., Costabel, U. Am. J. Respir. Crit. Care Med. (1995) [Pubmed]
  3. Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Limper, A.H., Colby, T.V., Sanders, M.S., Asakura, S., Roche, P.C., DeRemee, R.A. Am. J. Respir. Crit. Care Med. (1994) [Pubmed]
  4. Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis. Taha, R.A., Minshall, E.M., Olivenstein, R., Ihaku, D., Wallaert, B., Tsicopoulos, A., Tonnel, A.B., Damia, R., Menzies, D., Hamid, Q.A. Am. J. Respir. Crit. Care Med. (1999) [Pubmed]
  5. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. Pinkston, P., Bitterman, P.B., Crystal, R.G. N. Engl. J. Med. (1983) [Pubmed]
  6. Cyclosporin in pulmonary sarcoidosis. Rebuck, A.S., Sanders, B.R., MacFadden, D.K., Man, S.F., York, E.L., Cohen, R.D. Lancet (1987) [Pubmed]
  7. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. Agostini, C., Cassatella, M., Zambello, R., Trentin, L., Gasperini, S., Perin, A., Piazza, F., Siviero, M., Facco, M., Dziejman, M., Chilosi, M., Qin, S., Luster, A.D., Semenzato, G. J. Immunol. (1998) [Pubmed]
  8. Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis. Immunohistologic evidence that inflammatory macrophages express IL-2 receptors. Hancock, W.W., Kobzik, L., Colby, A.J., O'Hara, C.J., Cooper, A.G., Godleski, J.J. Am. J. Pathol. (1986) [Pubmed]
  9. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. Smedema, J.P., Snoep, G., van Kroonenburgh, M.P., van Geuns, R.J., Dassen, W.R., Gorgels, A.P., Crijns, H.J. J. Am. Coll. Cardiol. (2005) [Pubmed]
  10. Gas exchange at a given degree of volume restriction is different in sarcoidosis and idiopathic pulmonary fibrosis. Dunn, T.L., Watters, L.C., Hendrix, C., Cherniack, R.M., Schwarz, M.I., King, T.E. Am. J. Med. (1988) [Pubmed]
  11. Exhaled nitric oxide and bronchoalveolar lavage nitrite/nitrate in active pulmonary sarcoidosis. O'Donnell, D.M., Moynihan, J., Finlay, G.A., Keatings, V.M., O'Connor, C.M., McLoughlin, P., Fitzgerald, M.X. Am. J. Respir. Crit. Care Med. (1997) [Pubmed]
  12. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Baltzan, M., Mehta, S., Kirkham, T.H., Cosio, M.G. Am. J. Respir. Crit. Care Med. (1999) [Pubmed]
  13. Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. Adams, J.S., Singer, F.R., Gacad, M.A., Sharma, O.P., Hayes, M.J., Vouros, P., Holick, M.F. J. Clin. Endocrinol. Metab. (1985) [Pubmed]
  14. Does serum angiotensin converting enzyme reflect intensity of alveolitis in sarcoidosis? Cohen, R.D., Bunting, P.S., Meindok, H.O., Chamberlain, D.W., Rebuck, A.S. Thorax (1985) [Pubmed]
  15. Correlation of GM-CSF mRNA in bronchoalveolar fluid with indices of clinical activity in sarcoidosis. Itoh, A., Yamaguchi, E., Furuya, K., Hizawa, N., Ohnuma, N., Kawakami, Y., Kuzumaki, N. Thorax (1993) [Pubmed]
  16. 8-Isoprostane, a marker of oxidative stress, is increased in the expired breath condensate of patients with pulmonary sarcoidosis. Psathakis, K., Papatheodorou, G., Plataki, M., Panagou, P., Loukides, S., Siafakas, N.M., Bouros, D. Chest (2004) [Pubmed]
  17. Angiotensin-converting enzyme 2 (ACE2) haplotypes are associated with pulmonary disease phenotypes in sarcoidosis patients. Kruit, A., Ruven, H.J., Grutters, J.C., van den Bosch, J.M. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders. (2005) [Pubmed]
  18. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis. Mrazek, F., Holla, L.I., Hutyrova, B., Znojil, V., Vasku, A., Kolek, V., Welsh, K.I., Vacha, J., du Bois, R.M., Petrek, M. Tissue Antigens (2005) [Pubmed]
  19. Genomic instability on hMSH2, hMLH1, CD48 and IRF4 loci in pulmonary sarcoidosis. Demopoulos, K., Arvanitis, D.A., Vassilakis, D.A., Siafakas, N.M., Spandidos, D.A. Int. J. Biol. Markers (2002) [Pubmed]
  20. Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset. Saltini, C., Spurzem, J.R., Lee, J.J., Pinkston, P., Crystal, R.G. J. Clin. Invest. (1986) [Pubmed]
  21. CC and C chemokine expression in pulmonary sarcoidosis. Petrek, M., Kolek, V., Szotkowská, J., du Bois, R.M. Eur. Respir. J. (2002) [Pubmed]
  22. Lung compartmentalization of increased TNF releasing ability by mononuclear phagocytes in pulmonary sarcoidosis. Spatafora, M., Merendino, A., Chiappara, G., Gjomarkaj, M., Melis, M., Bellia, V., Bonsignore, G. Chest (1989) [Pubmed]
  23. Predictive value of bronchoalveolar T cell subsets for the course of pulmonary sarcoidosis. Costabel, U., Bross, K.J., Guzman, J., Nilles, A., Rühle, K.H., Matthys, H. Ann. N. Y. Acad. Sci. (1986) [Pubmed]
  24. Lung lavage neutrophils, neutrophil elastase and albumin in the prognosis of pulmonary sarcoidosis. Peros-Golubicić, T., Ivicević, A., Bekić, A., Alilović, M., Tekavec-Trkanjec, J., Smojver-Jezek, S. Collegium antropologicum. (2001) [Pubmed]
  25. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Petrek, M., Drábek, J., Kolek, V., Zlámal, J., Welsh, K.I., Bunce, M., Weigl, E., Du Bois, R. Am. J. Respir. Crit. Care Med. (2000) [Pubmed]
  26. Expression of macrophage inflammatory protein-3 beta/CCL19 in pulmonary sarcoidosis. Gibejova, A., Mrazek, F., Subrtova, D., Sekerova, V., Szotkowska, J., Kolek, V., du Bois, R.M., Petrek, M. Am. J. Respir. Crit. Care Med. (2003) [Pubmed]
  27. Inter-relationship between tumour necrosis factor-alpha (TNF-alpha) and TNF soluble receptors in pulmonary sarcoidosis. Armstrong, L., Foley, N.M., Millar, A.B. Thorax (1999) [Pubmed]
  28. Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis. Culver, D.A., Barna, B.P., Raychaudhuri, B., Bonfield, T.L., Abraham, S., Malur, A., Farver, C.F., Kavuru, M.S., Thomassen, M.J. Am. J. Respir. Cell Mol. Biol. (2004) [Pubmed]
  29. Involvement of discoidin domain receptor 1 in the deterioration of pulmonary sarcoidosis. Matsuyama, W., Mitsuyama, H., Watanabe, M., Shirahama, Y., Higashimoto, I., Osame, M., Arimura, K. Am. J. Respir. Cell Mol. Biol. (2005) [Pubmed]
  30. 67Ga scintigraphy as an index of disease activity in pulmonary sarcoidosis. Alberts, C., van der Schoot, J.B., Groen, A.S. European journal of nuclear medicine. (1981) [Pubmed]
  31. Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other inflammatory markers in pulmonary sarcoidosis. Prior, C., Barbee, R.A., Evans, P.M., Townsend, P.J., Primett, Z.S., Fyhrquist, F., Grönhagen-Riska, C., Haslam, P.L. Eur. Respir. J. (1990) [Pubmed]
  32. Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group. Pietinalho, A., Tukiainen, P., Haahtela, T., Persson, T., Selroos, O. Chest (1999) [Pubmed]
  33. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Utz, J.P., Limper, A.H., Kalra, S., Specks, U., Scott, J.P., Vuk-Pavlovic, Z., Schroeder, D.R. Chest (2003) [Pubmed]
  34. Calprotectin (MRP8/14 protein complex) release during mycobacterial infection in vitro and in vivo. Pechkovsky, D.V., Zalutskaya, O.M., Ivanov, G.I., Misuno, N.I. FEMS Immunol. Med. Microbiol. (2000) [Pubmed]
 
WikiGenes - Universities